Search This Blog

Tuesday, December 3, 2019

Oyster Point Pharma reports Q3 results

Oyster Point Pharma (NASDAQ:OYST): Q3 GAAP EPS of -$8.10.
Cash and cash equivalents of $72.28M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)